QuidelOrtho Corporation (QDEL)

NASDAQ: QDEL · IEX Real-Time Price · USD
47.94
-0.32 (-0.66%)
At close: Mar 28, 2024, 4:00 PM
45.75
-2.20 (-4.58%)
After-hours: Mar 28, 2024, 6:08 PM EDT

Company Description

QuidelOrtho Corporation provides diagnostic testing solutions.

The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units.

The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.

The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases.

The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings.

The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics.

The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use.

It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

QuidelOrtho Corporation
QuidelOrtho logo
Country United States
Founded 1979
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 7,100
CEO Michael S. Iskra

Contact Details

Address:
9975 Summers Ridge Road
San Diego, California 92121
United States
Phone (858) 552-1100
Website quidelortho.com

Stock Details

Ticker Symbol QDEL
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001906324
CUSIP Number 219798105
ISIN Number US2197981051
Employer ID 87-4496285
SIC Code 2835

Key Executives

Name Position
Robert J. Bujarski J.D. Interim President, Executive Vice President and Chief Operating Officer
Joseph M. Busky CPA Chief Financial Officer
Michelle A. Hodges Senior Vice President, General Counsel and Secretary
Dr. Werner Kroll Ph.D. Senior Vice President of Research and Development
Michael S. Iskra Interim Chief Executive Officer, Executive Vice President and Chief Commercial Officer
Louise M. Brandy Chief Information Officer
Patrick E. Klein Chief Administrative Officer
Ruben Argueta Director of Investor Relations
William J. Ferenczy Point of Care Business Unit Leader
Tamara A. Ranalli Molecular Diagnostics Business Unit Leader

Latest SEC Filings

Date Type Title
Feb 29, 2024 8-K/A [Amend] Current report
Feb 29, 2024 10-K Annual Report
Feb 21, 2024 8-K Current Report
Feb 16, 2024 8-K Current Report
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 8-K Current Report
Jan 26, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Dec 1, 2023 8-K Current Report
Nov 2, 2023 10-Q Quarterly Report